Serum Sclerostin as a Possible Biomarker in Ankylosing Spondylitis: A Case-Control Study

<div>Correlation (Spearman’s rho) between serum levels of sclerostin and mSASSS in patients with AS. mSASSS: modified Stoke Ankylosing Spondylitis Spinal Score.</div>

Journal of Immunology Research

fig3

Figure 3

Figure 3: Serum Sclerostin as a Possible Biomarker in Ankylosing Spondylitis: A Case-Control Study 